| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Web Design > Six Common Web Site Design Flaws - If Something Is Hard To Use It Doesn't Get Used Very Much |
|
Just Other Articles - Six Common Web Site Design Flaws - If Something Is Hard To Use It Doesn't Get Used Very Much
1. Budgeting for initial site development and ignoring maintenance. Calendars and announcements seem like obvious reasons for site maintenance; but t According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product he fact is that there is no such thing as content that will never change. When a site becomes outdated it tells visitors that the site owner is sloppy and unreliable. ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in It announces clearly that there is no reason to look further at the site or to return to the site.
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. commitment that cannot be overlooked. 2. The home page does not quickly and clearly identify the site and tell visitors why they should be there. here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe trong> The home page has a big responsibility in the overall success of a site. While it may be used to accomplish many tasks, the home page absolutely must do two th d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ings --
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ually through persistent navigation. 3. The site contains multiple navigation systems. This becomes particularly troublesome when various easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi navigation schemes contradict, duplicate or compete with each other. Such schemes fight for visitors' attention, bogging them down, putting them off and sidetracking t nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically hem.
4. Letting visitors get lost - no indication of current and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ page. The virtual reality world of a Web site makes it easy to get lost or to feel lost. Page identification should be obvious. There are very good reasons t ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi use page titles in the browser title bar, but since people rarely notice the title bar, it's not enough to prevent visitors from getting lost.
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a should indicate the current page. 5. The site's style is inconsisten dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod t. The way you handle information on one page is the way you handle information on every page.
cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin tyle, buttons and link text, descriptions, page titles and copy heads, etc. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen some photos, use them on all photos. t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel colored blue on one page, they should be the same on all pages. 6. Using backgrounds that reduce readability and obscure content. Patterne ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust d and even solid color backgrounds can make text difficult to read. Years ago, I participated in a university study of computer screen readability.
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products on a white background is the easiest to read. . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de on a dark background it needs sufficient contrast and weight to be workable. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip rk and should have large un-patterned sections where type can be placed. If something is hard to use it doesn't get used very much. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:4 Ways to Streamline Your Business and Increase Profits Online Article Marketing and Other Concepts Along This Theme 3 Top Ways to Create More Money In Search Engine Marketing
|